Cargando…
Greater Durability and Protection against Herpes Simplex Viral Disease following Immunization of Mice with Single-Cycle ΔgD-2 Compared to an Adjuvanted Glycoprotein D Protein Vaccine
Herpes simplex viruses (HSV) cause chronic infections with significant morbidity. Prior vaccines, designed to generate neutralizing antibodies (nAbs) targeting glycoprotein D (gD), failed to provide durable protection. We adopted a different strategy and evaluated a single-cycle virus deleted in gD...
Autores principales: | Mahant, Aakash Mahant, Gromisch, Matthew S., Kravets, Leah, Burn Aschner, Clare, Herold, Betsy C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10458853/ https://www.ncbi.nlm.nih.gov/pubmed/37631930 http://dx.doi.org/10.3390/vaccines11081362 |
Ejemplares similares
-
A non-neutralizing glycoprotein B monoclonal antibody protects against herpes simplex virus disease in mice
por: Kuraoka, Masayuki, et al.
Publicado: (2023) -
210 Antibody function, antigenic target and glycans determine the transfer of herpes simplex virus (HSV) antibodies (Abs) from mothers to newborns and transfer is altered by SARS-CoV-2
por: Mahant Mahant, Aakash, et al.
Publicado: (2022) -
Antibodies Elicited in Response to a Single Cycle Glycoprotein D Deletion Viral Vaccine Candidate Bind C1q and Activate Complement Mediated Neutralization and Cytolysis
por: Visciano, Maria Luisa, et al.
Publicado: (2021) -
Maternal Immunization with a Single-Cycle Herpes Simplex Virus (HSV) Candidate Vaccine, ΔgD-2, Protects Neonatal Mice from Lethal Viral Challenge
por: Kao, Carol, et al.
Publicado: (2017) -
Vaccination Route as a Determinant of Protective Antibody Responses against Herpes Simplex Virus
por: Burn Aschner, Clare, et al.
Publicado: (2020)